Sort
11,323 grants matching “glioblastoma”
Therapy of glioblastoma with novel apoptotic peptide
$263,163Northern California Institute Res &Educ · R01 · FY2003 · CA
Magnetic Resonance Elastography of the Brain
$263,150Samuel Patz · Brigham And Women'S Hospital · R21 · FY2016 · EB
Functional analysis of pathogenic mutations in Neurofibromatosis Type-1 (NF1)
$263,150James Anthony Walker · Massachusetts General Hospital · R21 · FY2016 · NS
'Arresting' bone marrow T cell sequestration in patients with GBM
$263,109Peter Fecci · Duke University · P50 · FY2020 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$263,103Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$263,103Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
The Role of Lyn in Glioma Progression and Migration
$263,099Candece L Gladson · University Of Alabama At Birmingham · R01 · FY2007 · CA
The Role of Lyn in Glioma Progression and Migration
$263,099Candece L Gladson · University Of Alabama At Birmingham · R01 · FY2008 · CA
Suppression of glioma invasion by a bicistronic constuct
$263,072Jasti S Rao · University Of Illinois At Chicago · R01 · FY2007 · CA
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides
$262,845James K Turkson · Cedars-Sinai Medical Center · R01 · FY2019 · CA
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma
$262,808Louis B Nabors · University Of Alabama At Birmingham · R01 · FY2020 · CA
Invasion and Angiogenesis in Malignant Gliomas
$262,798David Zagzag · New York University School Of Medicine · R01 · FY2007 · CA
Invasion and Angiogenesis in Malignant Gliomas
$262,798David Zagzag · New York University School Of Medicine · R01 · FY2008 · CA
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma
$262,751Alexander H. Stegh · Northwestern University At Chicago · P50 · FY2021 · CA
Core C - The Molecular Systems Pathology Core
$262,699Carlos Cordon-Cardo · Columbia Univ New York Morningside · P01 · FY2017 · CA
Regulatory Network Differences/Diverse Tumor Subtypes/Design Combinatorial Therap
$262,672Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA
Microenvironment determinants of radio-sensitivity in human high grade glioma
$262,500Christopher Paul Cifarelli · West Virginia University · P20 · FY2019 · GM
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$262,500University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$262,500University Of Texas Md Anderson Can Ctr · R01 · FY2001 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$262,500University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$262,500University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
$262,476James Culvin Morris · Clemson University · R21 · FY2024 · AI
Polynuclear Platinums in Targeted and Combination Glioma Therapy
$262,394Oliver Bogler · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Polynuclear Platinums in Targeted and Combination Glioma Therapy
$262,394Oliver Bogler · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
CNS Tumor Treatment Exploiting Viral Neuropathogenesis
$262,376Matthias Gromeier · Duke University · P50 · FY2007 · NS